Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Escudero

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment ResistanceDavid Bakhshinyan, Stefan Custers, Laura Escudero, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|April 25, 2021
Comparative anatomo-radiological study of intrahepatic venous vascularization in the SpainPablo Arviza, Asier Bombín, Juan Arrazola, et al.
Haematologica|February 22, 2020
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomasSabela Bobillo, Marta Crespo, Laura Escudero, et al.
Nature Communications|October 28, 2020
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastomaLaura Escudero, Anna Llort, Alexandra Arias, et al.
Nature Communications|March 9, 2021
Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironmentCarlota Rubio-Perez, Ester Planas-Rigol, Juan L Trincado, et al.
Nature Communications|June 13, 2019
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8<sup>+</sup> T cell tumor-infiltration impairing anti-PD1 therapyMónica Pascual-García, Ester Bonfill-Teixidor, Ester Planas-Rigol, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Endocrinologia, Diabetes Y Nutricion|May 16, 2025
Study of the C228T mutation of the TERT promoter in thyroid aspirative punctures of IV category of the Bethesda classificationBerta Bella Burgos, Ruben Carrera Salas, Ricard Onieva Carbajo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025
Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment ResistanceDavid Bakhshinyan, Stefan Custers, Laura Escudero, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|April 25, 2021
Comparative anatomo-radiological study of intrahepatic venous vascularization in the SpainPablo Arviza, Asier Bombín, Juan Arrazola, et al.
Haematologica|February 22, 2020
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomasSabela Bobillo, Marta Crespo, Laura Escudero, et al.
Nature Communications|October 28, 2020
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastomaLaura Escudero, Anna Llort, Alexandra Arias, et al.
Nature Communications|March 9, 2021
Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironmentCarlota Rubio-Perez, Ester Planas-Rigol, Juan L Trincado, et al.
Nature Communications|June 13, 2019
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8<sup>+</sup> T cell tumor-infiltration impairing anti-PD1 therapyMónica Pascual-García, Ester Bonfill-Teixidor, Ester Planas-Rigol, et al.
Cell Reports. Medicine|October 4, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastasesAgata M Kieliszek, Daniel Mobilio, Blessing I Bassey-Archibong, et al.
Cancer Cell|November 11, 2022
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastomaWilliam D Gwynne, Yujin Suk, Stefan Custers, et al.
Endocrinologia, Diabetes Y Nutricion|May 16, 2025
Study of the C228T mutation of the TERT promoter in thyroid aspirative punctures of IV category of the Bethesda classificationBerta Bella Burgos, Ruben Carrera Salas, Ricard Onieva Carbajo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell functionAgata M Kieliszek, Erika Apel, Suky Zheng, et al.
Pageof 3